Suppr超能文献

评估一种新型粪便抗原检测试剂检测克拉霉素耐药幽门螺杆菌的方法。

Assessment of a novel method to detect clarithromycin-resistant Helicobacter pylori using a stool antigen test reagent.

机构信息

Department of Pediatrics, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga-shi, Saga, 849-8501, Japan.

Division of Gastroenterology, Department of Internal Medicine, Imamura Hospital, Tosu, Japan.

出版信息

BMC Gastroenterol. 2020 Nov 23;20(1):397. doi: 10.1186/s12876-020-01549-9.

Abstract

BACKGROUND

The resistance rate of Helicobacter pylori to clarithromycin (CAM) is high among infected children in Japan. Therefore, a new method for detecting CAM-resistant H. pylori using a minimally invasive technique is strongly desired. We aimed to investigate the clinical usefulness of our newly developed nested polymerase chain reaction-quenching probe (Nested PCR-QP) method using stool specimens.

METHODS

We first evaluated our method using a residual solution of the H. pylori stool antigen test for adolescents. Then, we evaluated our method using culture testing for adults.

RESULTS

Among 57 middle school students with H. pylori, the Nested PCR-QP test results of 53 (90.3%) were able to be analyzed. A total of 28 students had CAM resistance mutations. We found a genetic mutation in 28 students and no mutation in 23 students, and these results were consistent with those of PCR-direct sequencing. In the 23 adults who were diagnosed with H. pylori infection using the rapid urease test and culture testing, we were able to use Nested PCR-QP for analyzing 21 adults who tested positive in the stool H. pylori antigen test. The results obtained for all 21 adults were consistent with those obtained via the drug susceptibility test.

CONCLUSIONS

Our novel method could be useful for non-invasively detecting CAM resistance mutations in H. pylori. This may help select a drug to reduce eradication failure rates against H. pylori. Trial registration This study was registered with the University Hospital Medical Information Network Clinical Trials Registry (no. UMIN000030632, https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034977 ) on 29 December 2017.

摘要

背景

在日本,感染儿童的幽门螺杆菌对克拉霉素(CAM)的耐药率很高。因此,强烈需要一种使用微创技术检测 CAM 耐药幽门螺杆菌的新方法。我们旨在使用粪便标本研究我们新开发的嵌套聚合酶链反应-淬灭探针(Nested PCR-QP)方法的临床实用性。

方法

我们首先使用青少年幽门螺杆菌粪便抗原检测的残留溶液评估我们的方法。然后,我们使用成人培养检测评估我们的方法。

结果

在 57 名中学生中,53 名(90.3%)的 Nested PCR-QP 检测结果可进行分析。共有 28 名学生有 CAM 耐药突变。我们在 28 名学生中发现了遗传突变,在 23 名学生中没有发现突变,这些结果与 PCR-直接测序的结果一致。在通过快速尿素酶试验和培养试验诊断为幽门螺杆菌感染的 23 名成年人中,我们能够使用 Nested PCR-QP 分析 21 名粪便幽门螺杆菌抗原检测呈阳性的成年人。所有 21 名成年人的结果均与药敏试验结果一致。

结论

我们的新方法可用于非侵入性地检测幽门螺杆菌中的 CAM 耐药突变。这可能有助于选择药物来降低幽门螺杆菌根除失败率。

试验注册

本研究于 2017 年 12 月 29 日在大学医院医疗信息网络临床试验注册中心(注册号 UMIN000030632,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034977)注册。

相似文献

5
Establishment of a nested-ASP-PCR method to determine the clarithromycin resistance of Helicobacter pylori.
World J Gastroenterol. 2016 Jul 7;22(25):5822-30. doi: 10.3748/wjg.v22.i25.5822.
6
Smart Gene™ as an effective non-invasive point-of-care test to detect Helicobacter pylori clarithromycin-resistant mutation.
J Gastroenterol Hepatol. 2022 Sep;37(9):1719-1725. doi: 10.1111/jgh.15887. Epub 2022 May 23.
9
Real-Time Polymerase Chain Reaction for the Detection of and Clarithromycin Resistance.
Gut Liver. 2023 May 15;17(3):375-381. doi: 10.5009/gnl220076. Epub 2022 Jul 20.

引用本文的文献

2
The prevalence of clarithromycin-resistant isolates: a systematic review and meta-analysis.
PeerJ. 2023 Mar 30;11:e15121. doi: 10.7717/peerj.15121. eCollection 2023.
3
The State of the Art of Molecular Fecal Investigations for () Antibiotic Resistances.
Int J Mol Sci. 2023 Feb 22;24(5):4361. doi: 10.3390/ijms24054361.
4
Commentary: Tailored therapy for eradication: A systematic review and meta-analysis.
Front Pharmacol. 2022 Dec 20;13:1090776. doi: 10.3389/fphar.2022.1090776. eCollection 2022.
6
Clinical Evaluation of a Novel Stool Antigen Test Using Bioluminescent Enzyme Immunoassay for Detecting .
Can J Gastroenterol Hepatol. 2022 Apr 21;2022:5571542. doi: 10.1155/2022/5571542. eCollection 2022.
7
Diagnosis of Infection and Recent Advances.
Diagnostics (Basel). 2021 Jul 21;11(8):1305. doi: 10.3390/diagnostics11081305.

本文引用的文献

2
4
Effect of Helicobacter pylori eradication on the incidence of gastric cancer: a systematic review and meta-analysis.
Gastric Cancer. 2019 May;22(3):435-445. doi: 10.1007/s10120-018-0876-0. Epub 2018 Sep 11.
6
Epidemiology of and CagA-Positive Infections and Global Variations in Gastric Cancer.
Toxins (Basel). 2018 Apr 19;10(4):163. doi: 10.3390/toxins10040163.
8
World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat.
J Gastroenterol. 2018 Mar;53(3):354-361. doi: 10.1007/s00535-017-1407-1. Epub 2017 Nov 14.
9
Estimation of lifetime cumulative incidence and mortality risk of gastric cancer.
Jpn J Clin Oncol. 2017 Nov 1;47(11):1097-1102. doi: 10.1093/jjco/hyx128.
10
Effect on Helicobacter pylori eradication therapy against gastric cancer in Japan.
Helicobacter. 2017 Oct;22(5). doi: 10.1111/hel.12415. Epub 2017 Aug 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验